Morgan Stanley cuts GitLab stock price target on cautious outlook

Morgan Stanley cut its GitLab price target to $29 from $38 (maintaining Equalweight), applying a 15x FCF multiple vs 18x previously; the stock trades at $24.58 near its 52-week low of $23.10 and is down ~56% over the past year. GitLab beat FactSet consensus on Q4 revenue, operating margin and free cash flow, generated $222M FCF LTM and posted 26% revenue growth, but management guided FY27 growth of 15-17% versus ~19% expected, and MS flagged several nonrecurring FY26 benefits (~300bps) that won’t repeat. MS also cited moderation in net revenue retention, bookings scaling issues, go-to-market execution risk and minimal Duo Agent Platform revenue in FY27; the new PT is based on CY2027 FCF/share of $1.46 (~$261M at a 20% margin).

Analysis

The market is treating GitLab as a slow-growth software name with execution risk priced into its equity multiple; that creates a conditional payoff where upside depends more on re-rating than on near-term organic acceleration. The logical beneficiaries of continued caution are integrated platform vendors that can bundle code hosting and CI/CD into existing enterprise contracts — expect incremental deals to flow to incumbents and to narrow GitLab’s set of addressable wins in large procurement cycles.

Near-term catalysts that will move the stock are operational: measurable monetization of the new agent product, visible improvements in net retention within price-sensitive cohorts, and clarity on public-sector deal flow. These are binary-to-gradual readouts — a clear pickup in adoption metrics over one to two quarters could trigger a multiple reset, while continued slower bookings will keep downside limited but persistent unless churn steps up materially.

The asymmetric trade sits in optionality: downside appears capped versus a meaningful re-rating if product-led adoption accelerates and sales efficiency improves after GTM changes. Execution risk is the primary tail — a failed GTM rollout or a sticky cohort of price-sensitive customers would compress growth and keep the market’s discount intact for multiple quarters, while a clean set of adoption KPIs would be the fastest path to reclaiming lost valuation multiple.

Key Decisions for Investors

• Long GTLB call-spread (directional, capped risk): Buy Jan 2027 25/45 call spread sized to 1-2% portfolio risk. Rationale: low upfront premium for multiquarter optionality toward a multiple re-rate if adoption metrics improve; target 3x payoff, stop if share falls below $18 or if next-quarter product adoption metrics disappoint.
• Equity + hedge (income/defensive): Buy GTLB shares (up to 1.5% portfolio) and buy a six-month 20 put to limit downside. Rationale: captures steady FCF optionality while capping tail risk from execution misses; review hedge cost vs alternative call spread if implied vol rises.
• Pair trade (relative value): Go long GTLB and short a diversified small-/mid-cap software ETF (e.g., IGV) sized dollar-neutral for 3–6 months. Rationale: isolates company-specific execution/catalyst risk from sector moves; unwind if GTLB misses adoption milestones or sector breadth deteriorates sharply.
• Event-driven short (speculative): If next quarter’s guidance again disappoints while implied vol compresses, sell short-dated strength (sell into the pop) with a trailing stop at 30% gain. Rationale: market overreacts to sequential guidance misses; rapid mean reversion often follows once there is clarity on one product or segment performance — cap position size and use stop-loss to limit gamma exposure.